2014
DOI: 10.2174/2211738502666141014212524
|View full text |Cite
|
Sign up to set email alerts
|

Formulation Studies on Novel Self-Solidifying Self-Nanoemulsifying Drug Delivery Systems of Nebivolol Hydrochloride

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Primarily used for formulations containing Gelucire® 44/14 as a surfactant, this technique involves preparing a mixture of oil, surfactant, and co-surfactant and allowing it to solidify at room temperature or through freezing. Gelucire possesses both surfactant properties and the ability to solidify the mixture [38].…”
Section: Self-solidification By Surfactantmentioning
confidence: 99%
“…Primarily used for formulations containing Gelucire® 44/14 as a surfactant, this technique involves preparing a mixture of oil, surfactant, and co-surfactant and allowing it to solidify at room temperature or through freezing. Gelucire possesses both surfactant properties and the ability to solidify the mixture [38].…”
Section: Self-solidification By Surfactantmentioning
confidence: 99%
“…Few studies have been carried out to overcome the current challenges associated with oral administration of nebivolol, and that can provide a controlled and effective delivery of nebivolol. Fast dissolving tablets, nanoparticles, self-nanoemulsifying delivery systems, transdermal systems etc were attempted to improve bioavailability of this drug but resulted with limited success [8,11]. Thus the therapeutic efficacy of nebivolol for the successful therapy remains elusive.…”
Section: Introductionmentioning
confidence: 99%